Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer Pankaj BhargavaJohn L. MarshallNaiyer A. Rizvi Original Article Pages: 95 - 103
Dose escalation study of irinotecan combined with carboplatin for advanced non-small-cell lung cancer Koji TakedaShunichi NegoroMasahiro Fukuoka Original Article Pages: 104 - 108
A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer Ian OlverMargaret DavyLorraine Webster Original Article Pages: 109 - 114
Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel Srikanth C. NallaniMary GenterPankaj B. Desai Original Article Pages: 115 - 122
Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein Cecilia H. FuSagrario Martin-AragonVassilios I. Avramis Original Article Pages: 123 - 133
Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients Stefanie ReifDorothea KingreenUlrich Jaehde Original Article Pages: 134 - 140
Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines Martin J. EdelmanHeather QuamBrian Mullins Original Article Pages: 141 - 144
Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy Omar N. Al SafarjalaniXiao-Jian ZhouMahmoud H. el Kouni Original Article Pages: 145 - 150
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial Roy S. HerbstCathleen LynchArthur T. Skarin Original Article Pages: 151 - 159
Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice Maria V. PapadopoulouMing JiWilliam D. Bloomer Original Article Pages: 160 - 168
Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model Ping GuoJianguo MaJames M. Gallo Original Article Pages: 169 - 176
